Homoeopathic Management In The Treatment Of Oppositional Defiant Disorder In Childre
Phase 4
- Conditions
- Health Condition 1: F913- Oppositional defiant disorder
- Registration Number
- CTRI/2022/02/040634
- Lead Sponsor
- M THANGAPANDIYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children fulfilling the criteria of ODD based on Parent/Teacher Disruptive Behavior Disorder Rating Scale
Exclusion Criteria
Patients of other behavioural disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parent/Teacher Disruptive Behavior Disorder Rating ScaleTimepoint: At base line and after 6 month
- Secondary Outcome Measures
Name Time Method IT IS EXPECTED THAT PROPOSED STUDY WILL BE USEFUL IN REDUCING THE SYMPTOMS OF OPPOSITIONAL DEFIANT DISORDER AND TO IMPROVE THE QUALITY OF LIFE IN OPPOSITIONAL DEFIANT DISORDER CHILDRENTimepoint: AT BASELINE AND AFTER 6 MONTHS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie homoeopathic treatment for oppositional defiant disorder in children?
How does homoeopathic constitutional treatment compare to standard behavioral therapies for ODD in pediatric populations?
Are there specific biomarkers that predict response to homoeopathic interventions in F913 Oppositional Defiant Disorder?
What are the potential adverse events associated with homoeopathic management of childhood behavioral disorders?
What combination approaches or competitor drugs are being evaluated for F913 Oppositional Defiant Disorder in phase IV trials?